healthcare
Australia announces new $225m biotech venture capital fund
The Australian government will contribute A$125 million ($112.6 million) to the A$250 million Medical Research Innovation Fund (MRIF), with the private sector to make up the other half.
INCJ leads $11m investment in Japan blood biotech venture
The Innovation Network Corporation of Japan (INCJ) has led a JPY1.16 billion ($11.7 million) investment in Megakaryon Corp, which is developing technology to produce blood platelets using reprogrammed stem cells.
KKR, Bain to enter final bidding for Panasonic healthcare unit - report
KKR, Toshiba Corp. and a consortium including Bain Capital, Mitsui & Co. and Development Bank of Japan are expected to participate in the final round of bidding for Panasonic’s healthcare unit.
China-focused BVCF leads $25m round for MicuRx Pharma
BVCF, a China-focused private equity growth fund specializing in life sciences, has a led a $25 million Series B round for MicuRX Paharmaceuticals, a biopaharma firm developing next generation antibiotics. The round also includes existing backers Morningside...
PE firms bid for Fortis’ Quality Healthcare - report
The Carlyle Group, Advent International and Mitsui and Co. are among the 10 bidders for Hong Kong’s Quality Healthcare Medical Services, which is being sold by PE-backed Fortis Healthcare.
OrbiMed targets $300m for second Asia healthcare fund
Healthcare-focused private equity firm OrbiMed Advisors is targeting $300 million for its second Asia fund. The PE firm raised $188 million for its debut regional vehicle in 2008.
Abraaj, CDC back India’s Rainbow Hospitals
The Abraaj Group and CDC, the UK government’s development finance arm, have together committed $17.5 million to Rainbow Hospitals, a pediatric and maternity healthcare facility in the southern Indian state of Andhra Pradesh. The size of the stake was...
ASK Pravi invests $9.7m in India’s OMNI Hospitals
ASK Pravi Capital Advisors has invested INR600 million ($9.7 million) in the tertiary care OMNI Hospitals chain for a significant minority stake.
Actis makes another attempt to sell India’s Sterling Hospitals – report
Olympus Capital-backed DM healthcare and Temasek’s HealthCare Global (HCG) are reported to be making offers for Actis Capital's Sterling Hospitals.
Malaysia's Khazanah in Turkish insurance buyout, Abraaj exits
Malaysian sovereign wealth fund Khazanah Nasional has agreed to pay $252 million for a 90% stake in Turkish health insurer Acibadem Sigorta. The investment facilitates the exit of The Abraaj Group, which held a 50% stake in the business.
Multiples buys ICICI Venture's stake in Vikram Hospital
Multiples Alternate Asset Management has bought a 64% stake in Bangalore-based Vikram Hospital from ICICI Venture Funds Management, and also infused direct capital for debt repayment.
Standard Chartered boosts stake as India’s Fortis moves to cut debt
Standard Chartered Private Equity (SCPE) will invest a further $13.5 million in hospital chain Fortis Healthcare through a preferential allotment of shares, taking its total holding to around 2.7%.
Legend Capital joins funding round for heart valve implant maker
Legend Capital has participated in a $62.5 million Series C round of funding for Munich-based JenaValve Technology, a manufacturer of valve systems used to treat heart conditions. The company intends to apply to market products in China.
IndiaVenture eyes $25m first close on healthcare fund
IndiaVenture Advisors (IVA), the PE arm of Indian healthcare company Piramal Enterprises, expects to reach a first close at around INR1.5 billion ($25 million) next month on IndiaVenture Trust Fund II, which has a full target of INR10 billion.
China medical devices: Climbing the value chain
Driven by government policy, China's medical devices industry is growing rapidly and VC capital is flowing in. Picking winners requires a keen eye for new technology and potential distribution obstacles
Riverside buys controlling stake in NZ animal drug delivery group
Riverside has acquired a controlling interest in Hamilton-based animal drug delivery company Simcro for a undisclosed sum.
Southeast Asia’s unloved
Southeast Asia is in vogue, seen by many as an increasingly credible alternative to China and India. Indonesia, as the region’s only market of scale, has naturally attracted the most interest. Virtually every regional and global private equity firm...
Qiming promotes Nisa Leung to managing partner
Qiming Venture Partners has promoted Nisa Leung, the head of its healthcare practice, to managing partner.
Blackstone set for partial exit as Emcure Pharma files for IPO
The Blackstone Group will make a partial exit from its 2006 investment in India's Emcure Pharmaceuticals as the company targets a INR3 billion ($50.4 million) IPO.
ChrysCapital-backed Intas Pharma files for IPO
ChrysCapital Partners will exit the 10.16% stake held by Fund III in Ahmedabad-based formulations maker Intas Pharmaceuticals via an upcoming IPO. Another 6.25% stake will continue to be held by the PE firm's fifth fund.
KKR-backed GenesisCare taps US debt markets
GenesisCare, a healthcare business controlled by KKR, has become the latest Australian PE-backed company to refinance its debt via the US high-yield market. A string of corporates are taking advantage of strong liquidity in the US leveraged market, where...
Quadria hires Rajesh Singhal to boost India coverage
Quadria Capital has appointed Rajesh Singhal as principal managing partner. He will take responsibility for the education and healthcare portfolio companies in India Build-Out Fund I, a vehicle acquired from Milestone Religare Investment Advisors three...
SEAVI Advent reaches $125m first close on Fund VI
SEAVI Advent Private Equity, the Asian arm of Advent International, has reached a first close of $125 million on its six fund - SEAVI Advent Equity Fund VI. Commitments came from high net worth individuals, corporate institutions and family offices, while...
Indian pharma firm Cipla launches VC unit
Cipla, an India-based generic drug maker, has set up a VC arm – Cipla Ventures – to invest in biotechnology, medical devices and new chemical entities.